Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AcuraStem
AddedFeb 15, 2024
UpdatedJun 18, 2026
AcuraStem

AcuraStem

Series A

AcuraStem: A fast-growing startup innovating in precision medicine since 2016.

HQ
Monrovia, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

AcuraStem, founded in 2016, is a patient-based biotechnology company focused on developing innovative treatments for neurodegenerative diseases, particularly sporadic ALS and FTD. The company's core mission revolves around its proprietary disease-modeling platform, iNeuroRx®, which aims to revolutionize drug discovery for these conditions. AcuraStem's approach emphasizes patient-focused research to overcome the limitations of traditional animal models in drug development.

The company's iNeuroRx® platform is recognized as a best-in-class tool for discovering novel, effective, and broadly-acting treatments. AcuraStem's work addresses a critical gap in the pharmaceutical industry, where drug failures in clinical trials often stem from an overreliance on animal models. By prioritizing patient-based research, AcuraStem strives to improve the understanding of neurodegenerative diseases and increase the success rate of drug development in this challenging field.

AcuraStem - Similar Companies

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

NeuroX1 logo

NeuroX1

neurox1.com

Accera logo

Accera

Aspen Neuroscience logo

Aspen Neuroscience

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Acelot logo

Acelot

acelot.com

AlphaStem logo

AlphaStem

alpha-stim.com

AxoSim logo

AxoSim

axosim.com

Stem Pharm logo

Stem Pharm

stempharm.com

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

AivoCode logo

AivoCode

aivocode.com

Adrx logo

Adrx

adrxpharma.com

Cellaria logo

Cellaria

cellariabio.com

Herophilus logo

Herophilus

herophilus.com

Aracari Biosciences logo

Aracari Biosciences

AcuraStem - Quick Facts

Who are AcuraStem's competitors?

Companies similar to AcuraStem include CuraSen Therapeutics, NeuroX1, Accera and Aspen Neuroscience.

When was AcuraStem founded?

AcuraStem was founded in 2016.

Where is AcuraStem's headquarters located?

AcuraStem's headquarters is located in Monrovia, CA, US.

When was AcuraStem's last funding round?

AcuraStem's most recent funding round was for $7M (USD) in January 2024.

How much has AcuraStem raised to-date?

As of Jan 30, 2024, AcuraStem has raised a total of $12M (USD).

How many employees does AcuraStem have?

AcuraStem has 36 employees as of Feb 5, 2024.

AcuraStem - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotech
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified